AIM ImmunoTech, Inc. (AIM)
0.8107
-0.03
(-3.91%)
USD |
NYAM |
Feb 12, 16:00
0.8107
0.00 (0.00%)
After-Hours: 19:32
AIM ImmunoTech Total Assets (Quarterly) : 5.494M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.221B |
| Agenus, Inc. | 233.89M |
| Curis, Inc. | 27.64M |
| LadRx Corp. | 0.2601M |
| Plus Therapeutics, Inc. | 18.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.57M |
| Shareholders Equity (Quarterly) | -6.077M |
| Debt to Equity Ratio | -0.3847 |
| Current Ratio | 0.6369 |
| Net Debt Paydown Yield | 2.70% |